Type 2 DM: Medication and Lifestyle Modifications Webcast
For AAFP members only
Improve Type 2 DM Treatment and Earn Free CME
Type 2 diabetes mellitus (T2DM) is on the rise in the United States. In the average primary care practice it is likely one-third of patients over age 18 and half over age 65 have prediabetes. Learn the latest evidence-based recommendations and guidelines to help your T2DM patients find the best effective pharmacotherapy and lifestyle modifications to reduce risk.
Watch this hour-long presentation and earn 1 AAFP Prescribed credit. This activity is free for AAFP members.
Enhance your patient care today and earn up to 2 additional AAFP Prescribed credits when you complete the Translation to Practice® (t2p™) process.
About the Webcast
After completing this CME activity, you should be able to:
- Utilize the American Diabetes Association general recommendations for anti-hyperglycemic therapy in T2DM.
- Apply shared decision making models to develop comprehensive lifestyle modification plans that are tailored for each patient's unique characteristics and heath profiles, including cultural considerations and dietary preferences.
- Assess and re-assess patients' individual profiles and preferences as treatment plans develop and evolve.
Estimated time required to complete the full module: 1 hour
Original release date of webcast: June 2, 2017
Peter Ziemkowski, MD FAAFP, Associate Professor, Department of Family and Community Medicine, Western Michigan University, Homer Stryker MD School of Medicine, Kalamazoo
This Enduring Material activity, Type 2 DM: Medication and Lifestyle Modifications, has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. Term of approval begins May 31, 2017. Term of approval is for two years from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AAFP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Family Physicians designates this Enduring Material activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME activities approved for AAFP credit are recognized by the AOA as equivalent to AOA Category 2 credit.
Following this CME activity, participants will have the opportunity to earn an additional two Prescribed credits for participation in each Translation to Practice® exercise. Information on Translation to Practice® will be shared within the activity.
The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. Please note that medical information is constantly changing; the information contained in this activity was accurate at the time of publication. This material is not intended to represent the only, nor necessarily best, methods or procedures appropriate for the medical situations discussed. Rather, it is intended to present an approach, view, statement, or opinion of the faculty, which may be helpful to others who face similar situations.
The AAFP disclaims any and all liability for injury or other damages resulting to any individual using this material and for all claims that might arise out of the use of the techniques demonstrated therein by such individuals, whether these claims shall be asserted by a physician or any other person. Physicians may care to check specific details such as drug doses and contraindications, etc., in standard sources prior to clinical application. This material might contain recommendations/guidelines developed by other organizations. Please note that although these guidelines might be included, this does not necessarily imply the endorsement by the AAFP.
The content of this material/presentation in this CME activity will include discussion of unapproved or investigational uses of products or devices as indicated: Metformin: Its use for prevention of progression of prediabetes to overt diabetes will be discussed.
The faculty for this activity have made all reasonable efforts to ensure the information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation. Information regarding drugs (eg, administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and delivery systems is subject to change.
The reader is advised to check the manufacturer’s insert and medical references for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering any drug.